Mai 2006 - IOZK

HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination

2006-05-25/in Breast Cancer, Dendritic Cells, International Publications /von 2006-05-25 / Gene Ther. 2006 Oct;13(19):1391-402

Analysis of cell proliferation and cell death during in situ hyperthermic treatment of neoplastic cells: a case report of human non-Hodgkin lymphoma

2006-05-24/in Hyperthermia, International Publications, Malignant Lymphoma /von 2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-32

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients

2006-05-15/in International Publications, Malignant Melanoma /von 2006-05-15 / Int. J. Cancer 2006 May;118(10):2617-27

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy

2006-05-15/in Chronic Virus Hepatitis, International Publications /von 2006-05-15 / J. Immunol. 2006 May;176(10):6065-75

Virology- and immunology-based gene therapy for cancer

2006-05-12/in Dendritic Cells, International Publications /von 2006-05-12 / Cancer Immunol. Immunother. 2006 Nov;55(11):1420-5

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA

2006-05-05/in International Publications, Malignant Melanoma /von 2006-05-05 / Cancer Gene Ther. 2006 Oct;13(10):905-18

Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination

2006-05-04/in Hypernephroma, International Publications /von 2006-05-04 / Sao Paulo Med J 2006 May;124(3):161-2

A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides

2006-05-01/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2006-05-01 / Clin. Cancer Res. 2006 May;12(9):2817-25

Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer

2006-05-01/in Breast Cancer, International Publications /von 2006-05-01 / Int. J. Cancer 2006 May;118(9):2220-31

Targeting tumours by adoptive transfer of immune cells

2006-05-01/in Breast Cancer, International Publications /von 2006-05-01 / Clin. Exp. Pharmacol. Physiol. 2006 May-Jun;33(5-6):569-74